GU Cancers 2020 | Chemo eligibility: bladder cancer

VJOncology is committed to improving our service to you

Srikala Sridhar

Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses whether it is necessary to redefine cisplatin-ineligibility in metastatic urothelial cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter